The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University Peptide Therapy Prescription in 2025: Your Safe Guide FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 Review: Doctor Explains Benefits, Safety & Cancer Risk BPC 157 & The Gut Brain Axis: A Practitioner's Definitive Review of the Evidence